Continued strong revenue growth in Q3 2019: +9.1% to €944m
H1 2019: another semester of strong results growth
ORPEA acquires 28% of Exelus and rolls out a comprehensive and innovative telemedicine solution across all its facilities in France
Strong H1 2019 revenue growth: +9.6% to €1,840m
Adjustment of the conversion/exchange ratio of OCEANE bonds
Strong success of the issuance of approximately €500m million of Bonds Convertible into New Shares and/or Exchangeable for Existing Shares
ORPEA launches an offering of Bonds Convertible into New Shares and/or Exchangeable for Existing Shares for a maximum nominal amount of €500m
Strong growth of 9.4% in Q1 2019 revenue to €910 million
Another year of strong earnings growth in 2018
Strong growth in 2018 revenue: up 9% to €3,420m
